Search for Clinical Trial Results
Anthrax - 46 Studies Found
Status | Study |
Completed |
Study Name: Trial of rPA-102 Vaccine in Healthy Adult Volunteers Condition: Anthrax Date: 2005-01-05 Interventions: Biological: rPA102 |
Not yet recruiting |
Study Name: An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis Condition:
Date: 2017-03-17 Interventions:
|
Completed |
Study Name: Ciprofloxacin BioThrax Co-Administration Study Condition: Anthrax Date: 2012-12-14 Interventions:
|
Completed |
Study Name: Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults Condition: Anthrax Date: 2011-12-12 Interventions: Biological: BioThrax BioThrax, 0.5 mL administered subcutaneously on days 0, 14, and 28. |
Completed |
Study Name: Placebo-Controlled, Sequential Group, Single Dose, Dose-Escalation Study to Evaluate the Safety and PK of ETI-204 Condition: Anthrax Date: 2011-10-14 Interventions:
|
Completed |
Study Name: Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects Condition: Anthrax Date: 2010-12-17 Interventions:
|
Completed |
Study Name: Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9) Condition: Anthrax Date: 2010-09-13 Interventions:
|
Terminated |
Study Name: Ph1 Study of Valortim and Doxycycline in Humans Condition: Anthrax Date: 2009-08-24 Interventions:
|
Suspended |
Study Name: Ph1 Study of Valortim and Ciprofloxacin in Humans Condition: Anthrax Date: 2009-08-22 Interventions:
|
Completed |
Study Name: Open-Label, Randomized, Parallel Group Study to Assess the Safety, Tolerability and PK of ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers Condition: Inhalational Anthrax Date: 2013-09-20 Interventions:
|